Prof. Shen-Orr is also the director of the Zimin Institute for AI Solutions in Healthcare at the Technion, which develops technologies based on big data and machine learning to improve healthcare, and co-director of Tech.AI, the Technion’s AI umbrella organization. Most recently, he became the founding director of iTechAge, the new Technion Institute for Healthy Aging, and is co-chief science officer of the global non-profit, the Human Immunome Project.

Prof. Shen-Orr develops novel analytics that he applies to study the drivers of immune variation, particularly in the context of aging and evolution, and to further precision medicine. By identifying diagnostic biomarkers that evaluate immune health, he has developed a metric that gauges one’s “immune age,” a more accurate measure of health than chronological age.

Based on his academic research, Prof. Shen-Orr co-founded CytoReason, a PharmaAI global leader in computational disease biology. The company, where he serves as chief scientist, uses an artificial intelligence model of the immune system to advance drug development.

Prof. Shen-Orr holds a bachelor’s degree from the Technion and a Ph.D. from Harvard University.